- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
OncoMed Pharmaceuticals Inc+ Add to Watchlist
OMED:US24.9200 USD 0.7200 2.98%
As of 20:10:00 ET on 05/29/2015.
Company Profile for OncoMed Pharmaceuticals Inc (OMED)
OncoMed Pharmaceuticals, Inc. provides biotechnology research and development. The Company synthesizes oncogenic mutations in stem cells that allows the cells to grow without normal limitations in attempts to exploit therapies that selectively target tumor initiating cells. OncoMed Pharmaceuticals serves the healthcare industry and cancer therapy patients in the United States.
OncoMed Pharmaceuticals Inc
Key Executives for OncoMed Pharmaceuticals Inc (OMED)
|Paul J HastingsPresident/CEO||John A LewickiExec VP/Chief Scientific Ofcr|
|Sunil PatelSenior VP:Finance/CFO||Austin GurneySenior VP:Molecular & Cellular|
|Timothy Hoey "Tim"Senior VP:Cancer Biology||Jakob DupontSenior VP/Chief Medical Ofcr|
|Alicia J HagerVP/General Counsel||Michelle CorralSenior Dir:Investor Relations|